InsiderTrades

Form 4 for INO INOVIO PHARMACEUTICALS, INC.

Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-11 · accession 0001055726-22-000020 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-14 2022-03-11 INO Kim Jong Joseph CEO, Dir M - OptEx — +139.4K 1.46M +11% —
D 2022-03-14 2022-03-11 INO Kim Jong Joseph CEO, Dir F - Tax $3.22 -39.7K 1.42M -3% -$127.8K
D 2022-03-14 2022-03-11 INO Kim Jong Joseph CEO, Dir M - OptEx $0.00 -139.4K 139.4K -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-11 M A 139,387 — 1,462,325 D — — (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
2 Common Common Stock 2022-03-11 F D 39,698 $3.22 1,422,627 D — —
3 Derivative Restricted Stock Unit 2022-03-11 M D 139,387 $0.00 139,386 D — · — to — 139,387 Common Stock (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 418,160 restricted stock units is as follows: 139,387 shares vested on March 11, 2021; 139,387 shares vested on March 11, 2022; 139,386 shares will vest on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.